Antibody and T Cell Reactivity Response After SARS-CoV-2 BNT162b2 mRNA Vaccine in Hemodialysis Patients: A Single-Center Experience from Sweden

被引：0
|
作者：
Melin, Jan [1 ,2 ]
Svensson, Maria K. [1 ,2 ]
Albinsson, Bo [1 ,2 ]
Pauksens, Karlis [1 ,2 ]
机构：
[1] Akad Sjukhuset, Uppsala, Sweden
[2] Uppsala Univ, Uppsala, Sweden
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO0127
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [31] Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
    Psichogiou, Mina
    Karabinis, Andreas
    Poulakou, Garyphallia
    Antoniadou, Anastasia
    Kotanidou, Anastasia
    Degiannis, Dimitrios
    Pavlopoulou, Ioanna D.
    Chaidaroglou, Antigoni
    Roussos, Sotirios
    Mastrogianni, Elpida
    Eliadi, Irene
    Basoulis, Dimitrios
    Petsios, Konstantinos
    Leontis, Konstantinos
    Kakalou, Eleni
    Protopapas, Konstantinos
    Jahaj, Edison
    Pratikaki, Maria
    Syrigos, Konstantinos N.
    Lagiou, Pagona
    Gogas, Helen
    Tsiodras, Sotirios
    Magiorkinis, Gkikas
    Paraskevis, Dimitrios
    Sypsa, Vana
    Hatzakis, Angelos
    VACCINES, 2021, 9 (09)
  • [32] SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents
    Fenioux, Charlotte
    Teixeira, Luis
    Fourati, Slim
    Melica, Giovanna
    Lelievre, Jean Daniel
    Gallien, Sebastien
    Zalcman, Gerard
    Pawlotsky, Jean Michel
    Tournigand, Christophe
    JAMA ONCOLOGY, 2022, 8 (04) : 612 - 617
  • [33] Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests
    Kanji, Jamil N.
    Bailey, Ashley
    Fenton, Jayne
    Ling, Sean H.
    Rivera, Rafael
    Plitt, Sabrina
    Sligl, Wendy, I
    Taylor, Sean
    Turnbull, LeeAnn
    Tipples, Graham
    Charlton, Carmen L.
    VACCINE, 2021, 39 (39) : 5563 - 5570
  • [34] Myocarditis after BNT162b2 mRNA SARS-CoV-2 vaccine: low incidence and mild severity
    Liuzzo, Giovanna
    Volpe, Massimo
    EUROPEAN HEART JOURNAL, 2022, 43 (09) : 855 - 856
  • [35] Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
    Steensels, Deborah
    Pierlet, Noella
    Penders, Joris
    Mesotten, Dieter
    Heylen, Line
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1533 - 1535
  • [36] Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies
    Gressens, Simon B.
    Fourati, Slim
    Le Bouter, Anne
    Le Bras, Fabien
    Dupuis, Jehan
    Hammoud, Mohammad
    El Gnaoui, Taoufik
    Gounot, Romain
    Roulin, Louise
    Belhadj, Karim
    Haioun, Corinne
    Gallien, Sebastien
    Melica, Giovanna
    Lemonnier, Francois
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) : 885.e7 - 885.e11
  • [37] Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine
    Gambim Fonseca, Marcela Helena
    Matias Dinelly Pinto, Ana Carolina
    Souza Silva, Maria Francilene
    Lima de Melo, Amanda Campelo
    Vasconcelos, Germana Silva
    dos Santos, Eduardo Ruback
    de Carvalho Araujo, Fernanda Montenegro
    Monteiro de Andrade, Luiz Odorico
    EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1237 - 1240
  • [38] Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
    Kageyama, Takahiro
    Tanaka, Shigeru
    Etori, Keishi
    Hattori, Koto
    Miyachi, Kazusa
    Kasuya, Tadamichi
    Iwamoto, Taro
    Ikeda, Kei
    Igari, Hidetoshi
    Yokote, Koutaro
    Nakajima, Hiroshi
    VACCINE, 2022, 40 (14) : 2129 - 2133
  • [39] Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
    Venerito, Vincenzo
    Stefanizzi, Pasquale
    Fornaro, Marco
    Cacciapaglia, Fabio
    Tafuri, Silvio
    Perniola, Simone
    Iannone, Florenzo
    Lopalco, Giuseppe
    RMD OPEN, 2022, 8 (01):
  • [40] Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
    Richards, Nathan E.
    Keshavarz, Behnam
    Workman, Lisa J.
    Nelson, Michael R.
    Platts-Mills, Thomas A. E.
    Wilson, Jeffrey M.
    JAMA NETWORK OPEN, 2021, 4 (09)
12345